Validation of COMPAT-SF Spanish Translation
Part of paid clinical trials in Dallas, Texas.
- Sponsor
- Methodist Health System
- Study ID
- NCT06698302
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Questionnaires — BEHAVIORALAdminister translated COMPAT-SF questionnaires to Spanish-speaking CP patients
Study Details
Prospective translation validation pilot study that will collect data from Spanish-speaking CP patients seen at Methodist Dallas Medical Center (MDMC) beginning June 2024 through July 2027, in order to validate a Spanish-translated COMPAT-SF instrument.
Key Dates
- Start date
- Sep 13, 2024
- Status verified
- Jul 2024
- Primary completion
- Sep 13, 2026
- Completion
- Sep 13, 2026
Study Design
- Enrollment
- 100 participants (estimated)
Primary Outcome Measure
Face validity: [ Time Frame: through study completion, up to 18 months ]
Central Contacts
- Jeff Wilson2149471279
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Methodist Dallas Medical Center- Clinical Research Institute | Dallas | Texas | 75203 | - |
Find similar trials in Dallas, TX
Related Studies
- Analysis of Graft Function Following Autologous Islet TransplantationRecruiting · Baylor Research Institute · Dallas, Texas
- Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT)Recruiting · M.D. Anderson Cancer Center · Los Angeles, California
- Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 StudyRecruiting · M.D. Anderson Cancer Center · Los Angeles, California
- Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic DisordersRecruiting · Mayo Clinic · Phoenix, Arizona